// App-Quantinova.ai

P175 : MASTERPLANS: prediction of response to rituximab in SLE using a validated two-score system for interferon

Researchers

Presenter

  • Ade Alase

Principal Investigators

  • Zoe Wigston

  • Agata Burska, Md

  • Yuzaiful Md Yusof

  • John Reynolds

  • Miriam Wittmann

  • Ian Bruce

  • Edward M Vital

Medical Centers

  • Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Interferon

  • Rituximab

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved